Clinical Trial Update: Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy, safety, and tolerability of Zibotentan in combination with Dapagliflozin versus Dapagliflozin alone in chronic kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Zibotentan (zibotentan)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease With High Proteinuria | Phase 3 | Status: ACTIVE_NOT_RECRUITING